The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
Several technologies for hemoglobinopathies are being transferred to commercial partners
The Court dismissed Swiss drugmaker Roche’s plea for interim injunction
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Eliquis (apixaban) available at more than 40 per cent discount; Sotyktu to be offered at more than 80 per cent discount to current list price
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
BIL also holds an option to increase its equity stake by an additional 15%
Subscribe To Our Newsletter & Stay Updated